InvestorsHub Logo
Followers 17
Posts 3258
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Monday, 04/30/2018 12:27:34 PM

Monday, April 30, 2018 12:27:34 PM

Post# of 111073
"We continue to focus on advancing commercialization of our CaverStem™ procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative disc disease (StemSpine™) and our amniotic derived stem cell (AmnioStem™), as well as patents pending in the area of neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches to regenerative medicine which will broaden our intellectual property pipeline,"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News